Halozyme Therapeutics | Stammkapital



Ordinary Share Capital Veränderung Datum
Acadia Pharmaceuticals USD 16K 0 2024-12
Agios Pharmaceuticals USD 73K 0 2024-12
Alnylam Pharmaceuticals USD 1.29M 4K 2024-12
Amarin USD 305.2M 156K 2024-09
Amgen USD 33.53B 140M 2024-12
Baxter International USD 683M 0 2024-12
Cytokinetics USD 118K 0 2024-12
DBV Technologies USD 10.98M 1000 2024-09
Eli Lilly USD 592.4M 1.5M 2024-12
Halozyme Therapeutics USD 123K 4K 2024-12
Indivior 65M 2M 2024-09
Intra Cellular Therapies USD 11K 0 2024-12
Ionis Pharmaceuticals USD 158K 0 2024-12
MannKind USD 3.03M 276K 2024-12
Pfizer USD 480M 0 2024-12
United Therapeutics USD 800K 100K 2024-12



Halozyme Therapeutics Stammkapital - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Mar 2025.